Chantal Saunders

Chantal Saunders  


Executive Summary

Chantal Saunders specializes in intellectual property, with an emphasis on patent litigation and particularly pharmaceutical litigation under the Patented Medicines (Notice of Compliance) Regulations. She is a lawyer and registered patent agent in the Ottawa office of Borden Ladner Gervais LLP. Her practice also involves copyright and trademark infringement litigation, and Access to Information Act matters. She has appeared before the Federal Courts on patent, trademark and copyright matters. Chantal also advises clients with respect to data protection, and issues arising in respect of the Patent Register, and the Patented Medicine Prices Review Board.

Representative Work

  • Appeared before the Federal Court and the Federal Court of Appeal.
  • Acting as counsel for innovator companies in proceedings brought pursuant to the Patented Medicines (Notice of Compliance) Regulations.
  • Acting as counsel in patent infringement and patent impeachment actions.
  • Acting as counsel in trademark infringement and expungement proceedings.
  • Acting as counsel in a copyright infringement action.
  • Acting as counsel for innovator companies in judicial review proceedings relating to listing of patents on the Patent Register.
  • Advising clients with respect to data protection, listing patents on the Patent Register and reporting patents to the Patented Medicine Prices Review Board.

Publications & Presentations

Chantal is a frequent blogger on the “BLG Not-for-Profit and Charity Law in Canada Blog”. This Blog is intended to be of value to anyone in Canada who has any involvement with Not-For-Profit Organizations or Charities.
Not-for-Profit Blog - RSS Feed  Subscribe to this blog

  • Contributing Author and Co-Editor, BLG's Intellectual Property Weekly Abstracts Bulletin.
  • Co-Author, "Court Guidance Needed Under Sound Prediction Doctrine", Drug Development & Outsourcing Guide 2015, Contact Canada (with Beverley Moore).
  • Author, "Examinations for Discovery," Intellectual Property Disputes: Resolutions and Remedies, Carswell, 2003-present (with Kevin LaRoche; 2012 supplement).
  • Co- Author, "Sound Prediction in Canada: The Promise is Still Important," Drug Development & Outsourcing Guide 2014, Contact Canada (with Beverley Moore).
  • Author, "Changing Standards Re Patent Utility Problematic for Industry," Drug Development & Outsourcing Guide 2012, Contact Canada.
  • Contributing Editor, Canadian Food and Drug Legislation & Commentary, 2012 Edition, LexisNexis Canada, 2011.
  • Author, "Sufficiency of Disclosure and Sound Prediction Requirements in Canada," IPO Committee Newsletter, August 2011 (with Beverley Moore).
  • Author, "The Canadian Biotechnology Public Policy Agenda," Biotechnology Focus, September 2011 (with Beverley Moore and Jeffrey Graham).
  • Contributing Author, Life Sciences & Chemical Patent Practice in Canada: A Practical Guide, 3rd edition, Borden Ladner Gervais LLP, 2011, available free of charge at

Rankings & Recognitions

  • Recognized in the 2019 edition of Canadian Legal Lexpert® Directory (Intellectual Property).
  • Recognized in the 2018 edition of Managing Intellectual Property's IP Stars (Patent; Trademark).
  • Recognized in the 2019 edition (and since 2016) of Intellectual Asset Magazine's (IAM) Patent 1000 - The World's Leading Patent Professionals (Patent Litigation).
  • S​elected by peers for inclusion in the 2019 edition (and since 2015) of The Best Lawyers in Canada® (Intellectual Property Law).
  • Recognized in the 2016 edition of the Legal 500 Canada (Intellectual Property).